All Resources
App Note
Characterizing Adoptive Cell Therapies using Bruker Cellular Analysis' Proteomic Barcode Technology

Discover how our proteomic barcode technology measures single-cell cytokine secretions to provide unique functional insights into cancer immunotherapy.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

The importance of polyfunctional cells in adoptive cell therapy.
Tracking cellular functionality to optimize manufacturing.
The Bruker Cellular Analysis IsoCode® Single-Cell Secretome platform and Workflow.
Discovering predictive clinical biomarkers that correlate with clinical outcomes.
Pre-clinical product characterization for early insights into efficacy and function.
A Deeper Look

More about this App Note

Bruker Cellular Analysis as a Critical Guide Throughout the ACT Development Workflow

Successfully developing an ACT necessitates extensive knowledge of cellular behavior that can only be obtained from single-cell functional proteomics. Download this App Note to learn more!

Get the App Note